dorsaVi Limited ( (AU:DVL) ) has issued an announcement.
DorsaVi Limited reported a 7.9% increase in revenues to $663,925 for the half-year ended December 2024, driven by a rise in one-off revenue contracts. Despite a 15.7% reduction in losses to $578,542, the company maintained its focus on cost rationalization, evidenced by an 8.1% decrease in operating expenditure. The company’s cash position improved significantly, with cash and cash equivalents rising to $1,241,459, and net assets increasing by $655,814, indicating a stronger financial position.
More about dorsaVi Limited
DorsaVi Limited operates in the health technology industry, specializing in innovative motion analysis devices and wearable sensors. The company focuses on providing solutions for clinical, sports, and occupational health markets.
Average Trading Volume: 1,127,297
Technical Sentiment Consensus Rating: Buy
Current Market Cap: A$5.85M
For a thorough assessment of DVL stock, go to TipRanks’ Stock Analysis page.